Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir in HIV/HCV Coinfection
NCT01467479Phase 3Terminated
- Sponsor
- Vertex Pharmaceuticals
- Start
- Dec 2011
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of telaprevir in hepatitis C (HCV), sponsored by Vertex Pharmaceuticals. Started Dec 2011; status: terminated.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01467479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01467479.